Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

National Securities Corporation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 4
Rounds per year 0.07
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Medical
  • Health Care
  • B2B
Summary

National Securities Corporation appeared to be the Corporate Investor, which was created in 1947. The company was established in North America in United States. The main department of described Corporate Investor is located in the New York.

Speaking about the real fund results, this Corporate Investor is 80 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2011. Comparing to the other companies, this National Securities Corporation performs on 4 percentage points more the average number of lead investments. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2016.

The typical case for the fund is to invest in rounds with 1 participant. Despite the National Securities Corporation, startups are often financed by Western Technology Investment, Upstage Ventures, Stage One Capital. In the next rounds fund is usually obtained by Sands Capital Ventures, PBM Capital Group, Northpond Ventures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Candel, Fortress Biotech (Formerly Known as Coronado Biosciences), Ordergroove. Among the most successful fund investment fields, there are Enterprise Software, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of National Securities Corporation:
Typical Co-investors
National Securities Corporation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after National Securities Corporation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Children's Health Dallas, Texas, United States
Chuling Chuangtou China, Hangzhou, Zhejiang
CIO Angel Network India, Maharashtra, Mumbai
Crabtree Ventures Chicago, Illinois, United States
HALLEY Venture Partners California, Lafayette, United States
Impact Ventures Hungary Budapest, Hungary
KNet Investment Partners Seoul, Seoul-t'ukpyolsi, South Korea
Kuake Capital Chaoyang, China, Liaoning
Litorina Stockholm, Stockholm County, Sweden
Meakem Becker Venture Capital Pennsylvania, Sewickley, United States
NCP Northland Capital Partners -
Ningbo Mingge Touzi China, Ningbo, Zhejiang
PineBridge Investments New York, New York, United States
Robot Corp -
Sequoia Capital Global Equities California, Menlo Park, United States
Sloan Biotech Funds -
T.N. Incorporation -
University of Connecticut Connecticut, Storrs Mansfield, United States
Xerys France, Ile-de-France, Paris
Zheng He Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Medical
Therapeutics
$4M01 Feb 2021 California, United States

Ordergroove

Artificial Intelligence
B2B
E-Commerce
Enterprise Software
Subscription Service
$20M17 Jan 2017 New York, New York, United States

Candel

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
Therapeutics
$14M12 Sep 2016 Massachusetts, United States

Fortress Biotech

Biotechnology
Health Care
Life Science
Pharmaceutical
$25M06 Jul 2011 New York, New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent National Securities Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 13M
Rounds per year 0.07
Peak activity year 2021
Lead investments 3
Follow on index 0.20
Exits 1

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Medical
Therapeutics
$4M01 Feb 2021 California, United States

Ordergroove

Artificial Intelligence
B2B
E-Commerce
Enterprise Software
Subscription Service
$20M17 Jan 2017 New York, New York, United States

Candel

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
Therapeutics
$14M12 Sep 2016 Massachusetts, United States

Fortress Biotech

Biotechnology
Health Care
Life Science
Pharmaceutical
$25M06 Jul 2011 New York, New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors: